02Aug
FDA Issues Cannabidiol Marketing Warning as Congressional Pressure for Action Continues
Following through with its promise to take enforcement actions against companies marketing cannabis-derived products that could put consumers at risk, the Food and Drug Administration (FDA) recently issued a warning letter to Curaleaf Inc., a...
By:
Wilson Sonsini Goodrich & Rosati
Related
Basic threshold $94 million effective February 27 - Filing thresholds under the Hart-Scott-Rodino A...
Read More >
“What did I do wrong?” and “Am I doing this correctly?” are frequent questions from clients rega...
Read More >
Delaware recently passed a bill, House Bill 199 (HB 199), which, among other things, amends the crim...
Read More >
Yesterday, the full Ninth Circuit held that an employer cannot rely on an individual’s prior salary...
Read More >
Court Holds Member States Must Require Employers to Adopt Systems to Record All Employee Working Tim...
Read More >
As 2020 arrives, it is a time for everyone to reflect on the past year. For some, this will include ...
Read More >